thiazolyl blue has been researched along with peptide yy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grisé, KR; Laird, EC; McFadden, DW; Rongione, AJ | 1 |
| Heisler, T; McFadden, DW; Simon, N; Towfigh, S | 1 |
2 other study(ies) available for thiazolyl blue and peptide yy
| Article | Year |
|---|---|
Peptide YY inhibits growth of human breast cancer in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Coloring Agents; Cyclic AMP; Female; Humans; Intracellular Membranes; Mice; Mice, Nude; Peptide YY; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1999 |
Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Coloring Agents; Female; Humans; Peptide YY; Receptors, Estrogen; Tetrazolium Salts; Thiazoles; Tocopherols; Tumor Cells, Cultured; Vitamin E | 2000 |